Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy

Fig. 1

Decision approach for the primary prevention of VTEs and ATEs in primary MN patients. MN: membranous nephropathy; VTE: venous thromboembolic event; ALB: serum albumin; ATE: arterial thromboembolic event; HAS-BLED: hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly, Drugs/alcohol; HAS-BLED score ≥ 3: high bleeding risk; Adapted from Hofstra et al. [20] and Lee et al. [21]

Back to article page